MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-02-0017444
Sightom Pharmaceuticals Private Limited
Sightom Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹88.81 Lakh
▲ 15% YoY
Net profit · FY 2024
₹18,530
Net margin 0.2%
EBITDA · FY 2024
₹2.56 Lakh
EBITDA margin 2.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Sightom Pharmaceuticals Private Limited
Data last updated:
Sightom Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 April 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2016PTC298273. Its GSTIN is 07AAXCS0023R1ZP (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chandan Jain and Madhu Jain.
Its last annual general meeting (AGM) was held on 28 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Southern Side Plot No – 66/1 In Block A Rewari Line Industrial Area Phase – II Mayapuri, New Delhi, Delhi, India – 110064.
As per the financials filed for FY 2024, the company reported a revenue of ₹88.81 Lakh, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹18,530 (net margin 0.2%) and EBITDA of ₹2.56 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years and 30% over five years.
Sightom Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0017444). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999DL2016PTC298273
Registration Number 298273
Incorporation Date 18 April 2016
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 28 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-02-0017444
Key People
Chandan Jain Director Madhu Jain Director Recognitions & Rankings of Sightom Pharmaceuticals
Contact details
Sightom Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSouthern Side Plot No – 66/1 In Block A Rewari Line Industrial Area Phase – II Mayapuri, New Delhi, Delhi, India – 110064
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sightom Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Sightom Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sightom Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Sightom Pharmaceuticals Private Limited, buy the company report.
Financials of Sightom Pharmaceuticals Private Limited
FY 2025 filings availableSightom Pharmaceuticals Private Limited reported revenue of ₹88.81 Lakh (up 15% YoY) for FY 2024.
Revenue · FY 2024
₹88.81 Lakh ▲ 15%
Net profit · FY 2024
₹18,530 margin 0.2%
EBITDA · FY 2024
₹2.56 Lakh margin 2.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 34%
5 years · compounded
▲ 30%
EBITDA CAGR growth
1 year
▲ 30%
3 years · compounded
▼ 5%
5 years · compounded
▲ 19%
Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 15% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.56 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹18,530 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sightom Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sightom Pharmaceuticals Private Limited
Sightom Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandan Jain | Director | 18 Apr 2016 | 10 Years 6 Months | Current |
| Madhu Jain | Director | 05 May 2018 | 8 Years 5 Months | Current |
Auditor
Sightom Pharmaceuticals Private Limited is audited by POOJA G & CO. for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| POOJA G & CO. | FY 2019 | 033305N |
Shareholding
The shareholding of Sightom Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sightom Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sightom Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sightom Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sightom Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAXCS0023R1ZP | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sightom Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sightom Pharmaceuticals Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Madhu Jain ceased to be Additional Director on 01 Jun 2018.
AGM
Sightom Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Sep 2025 as per latest MCA records.
Filing
Sightom Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Ceased
Madhu Jain ceased to be Additional Director.
Ceased
Meenakshi Aggarwal ceased to be Director.
Appointed
Madhu Jain was appointed as Director.
Appointed
Chandan Jain was appointed as Director.
Incorporation
18 Apr 2016
Sightom Pharmaceuticals Private Limited was registered on 18 Apr 2016 with Roc Delhi Ii & aged 10 years 6 months as per MCA records.
Frequently asked questions
Sightom Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 April 2016 (10+ years old) and is registered under CIN U74999DL2016PTC298273.
Sightom Pharmaceuticals has 2 current directors:
- Chandan Jain - Director
- Madhu Jain - Director
The latest financial statements of Sightom Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Sightom Pharmaceuticals is 07AAXCS0023R1ZP, registered in Delhi.
The CIN (Corporate Identification Number) of Sightom Pharmaceuticals is U74999DL2016PTC298273. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sightom Pharmaceuticals was incorporated on 18 April 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
Madhu Jain ceased to be Additional Director on 01 Jun 2018. Meenakshi Aggarwal ceased to be Director on 07 May 2018. Madhu Jain was appointed as Director on 05 May 2018. Sightom Pharmaceuticals has 4 board changes on record in total.
Yes, Sightom Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0017444).
The registered office of Sightom Pharmaceuticals is at Southern Side Plot No – 661 In Block A Rewari Line Industrial Area Phase – II Mayapuri, New Delhi, Delhi, India – 110064.
Sightom Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.